Promising Biologic Freeze-Dried Plasma Study Data to Be Released; Westat Finalizing Design of Confirmatory Trial

Research results about a biologic freeze-dried plasma (FDP) are to be released this month, bringing us closer to meeting a critical clinical need in both U.S. military and civilian populations to treat patients with hemorrhage and severe bleeding.

Principal Investigator Dr. Jose Cancelas, M.D., Ph.D., of the University of Cincinnati’s Hoxworth Blood Center will present the abstract, Safety Analysis of a New Generation Of Freeze-Dried Plasma: Report of a Completed Dose-Escalation, Phase 1 Clinical Trial.  Melissa King, a Westat Vice President, and Michele Snyder, a Westat project manager, are contributing authors. The presentation will take place at the 2018 Annual AABB Meeting October 13-16, 2018, in Boston.

Unlike fresh frozen plasma, FDP can be prepared for immediate infusion in less than 2 minutes versus the nearly 2 hours to prepare fresh frozen plasma for infusion. FDP also has less rigorous storage requirements than fresh frozen plasma, offering advantages for use in settings with limited or no access to fresh frozen plasma. 

Westat is finalizing the development of the phase II confirmatory trial and will manage its conduct across multiple sites in 2019. 

The U.S. Army Medical Materiel Development Activity is sponsoring the development and needed trials for FDP in anticipation of submitting a biologic licensing application to the Food and Drug Administration. The product is being developed and manufactured by Vascular Solutions Inc., a wholly owned subsidiary of Teleflex. 

Want to work with us?
You’ll be in great company.

About Us Careers

Two people looking at phone
Two people talking
Client List
AAA Foundation for Traffic Safety
Baltimore Metropolitan Council
Centers for Disease Control and Prevention
Centers for Medicare & Medicaid Services
Chicago Metropolitan Agency for Planning
ClearWay Minnesota
DC Public Schools
Georgia Department of Transportation
Internal Revenue Service
Maryland Cancer Registry
Michigan Department of Health and Human Services
National Science Foundation
NYC Mayor’s Office for Economic Opportunity
Organization for Economic Cooperation and Development
Robert Wood Johnson Foundation
SiriusXM
Social Security Administration
Substance Abuse and Mental Health Services Administration
Teach for America
Texas Education Agency
The Johns Hopkins University
The National Institutes of Health
The Verizon Foundation
Toyota
U.S. Department of Agriculture
U.S. Department of Education
U.S. Department of Health and Human Services
U.S. Department of Justice
U.S. Department of Transportation
U.S. Department of Veterans Affairs
University of Denver
University of Maryland Baltimore Campus
University of Michigan

Westat is an Equal Opportunity Employer and does not discriminate on the basis of race, color, religion, sex, national origin, age, veteran status, disability, marital status, sexual orientation, citizenship status, genetic information, gender identity, or any other protected status under applicable law. Notices to Employees & Applicants.